Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday

Nautilus Biotechnology (NASDAQ:NAUT) will be posting its quarterly earnings results before the market opens on Tuesday, October 29th. Analysts expect Nautilus Biotechnology to post earnings of ($0.17) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Nautilus Biotechnology (NASDAQ:NAUT) last released its earnings results on Tuesday, July 30th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02. During the same period in the previous year, the firm posted ($0.13) earnings per share. On average, analysts expect Nautilus Biotechnology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nautilus Biotechnology Stock Down 1.1 %

NAUT opened at $2.69 on Friday. The stock has a market cap of $336.96 million, a PE ratio of -4.89 and a beta of 1.22. The business has a 50 day moving average of $2.73 and a 200-day moving average of $2.61. Nautilus Biotechnology has a 52 week low of $2.19 and a 52 week high of $3.45.

Insider Activity

In other Nautilus Biotechnology news, VP Mary E. Godwin sold 47,031 shares of Nautilus Biotechnology stock in a transaction on Monday, September 23rd. The stock was sold at an average price of $2.87, for a total transaction of $134,978.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 40.50% of the stock is currently owned by company insiders.

About Nautilus Biotechnology

Nautilus Biotechnology, Inc, a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.